AUPN953896A0 - Treatment of t-cell mediated diseases - Google Patents

Treatment of t-cell mediated diseases

Info

Publication number
AUPN953896A0
AUPN953896A0 AUPN9538A AUPN953896A AUPN953896A0 AU PN953896 A0 AUPN953896 A0 AU PN953896A0 AU PN9538 A AUPN9538 A AU PN9538A AU PN953896 A AUPN953896 A AU PN953896A AU PN953896 A0 AUPN953896 A0 AU PN953896A0
Authority
AU
Australia
Prior art keywords
treatment
mediated diseases
cell mediated
diseases
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN9538A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Womens and Childrens Hospital Adelaide
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Womens and Childrens Hospital Adelaide
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens and Childrens Hospital Adelaide, Peptide Technology Ltd filed Critical Womens and Childrens Hospital Adelaide
Priority to AUPN9538A priority Critical patent/AUPN953896A0/en
Publication of AUPN953896A0 publication Critical patent/AUPN953896A0/en
Priority to GB9822203A priority patent/GB2328155B/en
Priority to US09/171,095 priority patent/US6262119B1/en
Priority to EP97916266A priority patent/EP0904072A4/en
Priority to AU24988/97A priority patent/AU726798B2/en
Priority to PCT/AU1997/000231 priority patent/WO1997038688A1/en
Priority to CA002251780A priority patent/CA2251780A1/en
Priority to JP9536587A priority patent/JP2000508645A/en
Abandoned legal-status Critical Current

Links

AUPN9538A 1996-04-12 1996-04-26 Treatment of t-cell mediated diseases Abandoned AUPN953896A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AUPN9538A AUPN953896A0 (en) 1996-04-26 1996-04-26 Treatment of t-cell mediated diseases
GB9822203A GB2328155B (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fattyacids
US09/171,095 US6262119B1 (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fatty acids
EP97916266A EP0904072A4 (en) 1996-04-12 1997-04-14 METHODS FOR TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTY ACIDS
AU24988/97A AU726798B2 (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fatty acids
PCT/AU1997/000231 WO1997038688A1 (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fattyacids
CA002251780A CA2251780A1 (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fatty acids
JP9536587A JP2000508645A (en) 1996-04-12 1997-04-14 Method for treating immune diseases using polyunsaturated fatty acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9538A AUPN953896A0 (en) 1996-04-26 1996-04-26 Treatment of t-cell mediated diseases

Publications (1)

Publication Number Publication Date
AUPN953896A0 true AUPN953896A0 (en) 1996-05-23

Family

ID=3793852

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN9538A Abandoned AUPN953896A0 (en) 1996-04-12 1996-04-26 Treatment of t-cell mediated diseases

Country Status (1)

Country Link
AU (1) AUPN953896A0 (en)

Similar Documents

Publication Publication Date Title
AU2092697A (en) Combinations for treatment of proliferative diseases
AU4582797A (en) Methods for treatment of retinal diseases
AU4411297A (en) Combination therapy for treatment of psychoses
AU4082797A (en) Intracorporeal light treatment of blood
AU6913796A (en) Patient treatment apparatus
AU2557397A (en) Removal of tissue
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU2935597A (en) Therapeutic treatment for vegf related diseases
AU2972497A (en) Treatment of oils
AUPM761094A0 (en) Treatment of hides
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU3552697A (en) Novel treatment of leptine resistance
AU1697197A (en) Immunoconjugate for the treatment of aids
AU2969597A (en) Treatment of vascular lesions
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
AU2870597A (en) Treatment of liquid
AU1926597A (en) Treatment of cocoa
AU4546096A (en) Treatment of waste
AU2754997A (en) The treatment of plant diseases
AU4027097A (en) Method of treatment
AUPN953896A0 (en) Treatment of t-cell mediated diseases
AU6171196A (en) Therapeutic uses of ta99
AUPO108596A0 (en) Treatment of obesity
AU4310397A (en) Treatment of waste
AU3163795A (en) Treatment of autoimmune diseases